NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Kidney Failure


Return to Library

Free Kidney Failure Articles


New findings from Sao Paulo Federal University, Division of Nephrology describe advances in depression quality of care



2009 AUG 24 - (NewsRx.com) -- Current study results from the report, 'Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients,' have been published. According to a study from Sao Paulo, Brazil, "Depression is an important target of psychological assessment in patients with end-stage renal disease because it predicts their morbidity, mortality, and quality of life. We assessed the effectiveness of cognitive-behavioral therapy in chronic hemodialysis patients diagnosed with major depression by the Mini International Neuropsychiatric Interview (MINI)."

"In a randomized trial conducted in Brazil, an intervention group of 41 patients was given 12 weekly sessions of cognitive-behavioral group therapy led by a trained psychologist over 3 months while a control group of 44 patients received the usual treatment offered in the dialysis unit. In both groups, the Beck Depression Inventory, the MINI, and the Kidney Disease and Quality of Life-Short Form questionnaires were administered at baseline, after 3 months of intervention or usual treatment, and after 9 months of follow-up. The intervention group had significant improvements, compared to the control group, in the average scores of the Beck Depression Inventory overall scale, MINI scores, and in quality-of-life dimensions that included the burden of renal disease, sleep, quality of social interaction, overall health, and the mental component summary," wrote P.S. Duarte and colleagues, Sao Paulo Federal University, Division of Nephrology.

The researchers concluded: "We conclude that cognitive-behavioral group therapy is an effective treatment of depression in chronic hemodialysis patients."

Duarte and colleagues published their study in Kidney International (Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney International, 2009;76(4):414-21).

For more information, contact P.S. Duarte, Federal University of Sao Paulo, Federal University of Sao Paulo, Division of Nephrology, Sao Paulo, Brazil.

Publisher contact information for the journal Kidney International is: Springer, 233 Spring Street, New York, NY 10013, USA.

Keywords: Brazil, Sao Paulo, Depression Quality of Care, Behavior, Chronic Kidney Failure, Clinical Trial Research, Depression, Hemodialysis, Mental Health, Nephrology, Psychiatry, Psychology, Quality of Care, Quality of Life, Renal Dialysis, Renal Disease, Therapy, Treatment.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login